Please provide your email address to receive an email when new articles are posted on . Atypical hemolytic uremic syndrome is a rare condition caused by the uncontrolled activation of complement, and ...
Please provide your email address to receive an email when new articles are posted on . Registry data showed efficacy of ravulizumab was similar to that of eculizumab. No unexpected adverse events ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results